Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Early Relapse in First-Line Follicular Lymphoma: A Review of the Clinical Implications and Available Mitigation and Management Strategies.

Oncology and therapy

Rodgers TD, Casulo C, Boissard F, Launonen A, Parreira J, Cartron G.
PMID: 34319556
Oncol Ther. 2021 Dec;9(2):329-346. doi: 10.1007/s40487-021-00161-5. Epub 2021 Jul 28.

Chemoimmunotherapy with rituximab (R-chemo) or obinutuzumab (G-chemo) is standard of care for patients with previously untreated symptomatic or high-tumor-burden follicular lymphoma. Median progression-free survival (PFS) with R-chemo plus R maintenance exceeds 10 years, and G-chemo plus G maintenance improves...

Cite
Rodgers TD, Casulo C, Boissard F, et al. Early Relapse in First-Line Follicular Lymphoma: A Review of the Clinical Implications and Available Mitigation and Management Strategies. Oncol Ther. 2021;9(2):329-346doi: 10.1007/s40487-021-00161-5.
Rodgers, T. D., Casulo, C., Boissard, F., Launonen, A., Parreira, J., & Cartron, G. (2021). Early Relapse in First-Line Follicular Lymphoma: A Review of the Clinical Implications and Available Mitigation and Management Strategies. Oncology and therapy, 9(2), 329-346. https://doi.org/10.1007/s40487-021-00161-5
Rodgers, Thomas D, et al. "Early Relapse in First-Line Follicular Lymphoma: A Review of the Clinical Implications and Available Mitigation and Management Strategies." Oncology and therapy vol. 9,2 (2021): 329-346. doi: https://doi.org/10.1007/s40487-021-00161-5
Rodgers TD, Casulo C, Boissard F, Launonen A, Parreira J, Cartron G. Early Relapse in First-Line Follicular Lymphoma: A Review of the Clinical Implications and Available Mitigation and Management Strategies. Oncol Ther. 2021 Dec;9(2):329-346. doi: 10.1007/s40487-021-00161-5. Epub 2021 Jul 28. PMID: 34319556; PMCID: PMC8594248.
Copy Download .nbib Format: NLM
Vaccination in pregnancy against pertussis and seasonal influenza: key learnings and components from high-performing vaccine programmes in three countries: the United Kingdom, the United States and Spain.

BMC public health

Baïssas T, Boisnard F, Cuesta Esteve I, Garcia Sánchez M, Jones CE, Rigoine de Fougerolles T, Tan L, Vitoux O, Klein C.
PMID: 34844567
BMC Public Health. 2021 Nov 29;21(1):2182. doi: 10.1186/s12889-021-12198-2.

BACKGROUND: Pertussis and seasonal influenza are responsible for significant maternal, neonatal, and infant morbidity and mortality, but vaccine coverage rates (VCR) for both pertussis (administered as a tetanus, diphtheria, acellular pertussis [Tdap] vaccination) and seasonal influenza in pregnancy remain...

Cite
Baïssas T, Boisnard F, Cuesta Esteve I, et al. Vaccination in pregnancy against pertussis and seasonal influenza: key learnings and components from high-performing vaccine programmes in three countries: the United Kingdom, the United States and Spain. BMC Public Health. 2021;21(1):2182doi: 10.1186/s12889-021-12198-2.
Baïssas, T., Boisnard, F., Cuesta Esteve, I., Garcia Sánchez, M., Jones, C. E., Rigoine de Fougerolles, T., Tan, L., Vitoux, O., & Klein, C. (2021). Vaccination in pregnancy against pertussis and seasonal influenza: key learnings and components from high-performing vaccine programmes in three countries: the United Kingdom, the United States and Spain. BMC public health, 21(1), 2182. https://doi.org/10.1186/s12889-021-12198-2
Baïssas, Théophile, et al. "Vaccination in pregnancy against pertussis and seasonal influenza: key learnings and components from high-performing vaccine programmes in three countries: the United Kingdom, the United States and Spain." BMC public health vol. 21,1 (2021): 2182. doi: https://doi.org/10.1186/s12889-021-12198-2
Baïssas T, Boisnard F, Cuesta Esteve I, Garcia Sánchez M, Jones CE, Rigoine de Fougerolles T, Tan L, Vitoux O, Klein C. Vaccination in pregnancy against pertussis and seasonal influenza: key learnings and components from high-performing vaccine programmes in three countries: the United Kingdom, the United States and Spain. BMC Public Health. 2021 Nov 29;21(1):2182. doi: 10.1186/s12889-021-12198-2. PMID: 34844567; PMCID: PMC8628032.
Copy Download .nbib Format: NLM
Effect of Size and Shape on Electrochemical Performance of Nano-Silicon-Based Lithium Battery.

Nanomaterials (Basel, Switzerland)

Keller C, Desrues A, Karuppiah S, Martin E, Alper JP, Boismain F, Villevieille C, Herlin-Boime N, Haon C, Chenevier P.
PMID: 33504062
Nanomaterials (Basel). 2021 Jan 25;11(2). doi: 10.3390/nano11020307.

Silicon is a promising material for high-energy anode materials for the next generation of lithium-ion batteries. The gain in specific capacity depends highly on the quality of the Si dispersion and on the size and shape of the nano-silicon....

Cite
Keller C, Desrues A, Karuppiah S, et al. Effect of Size and Shape on Electrochemical Performance of Nano-Silicon-Based Lithium Battery. Nanomaterials (Basel). 2021;11(2)doi: 10.3390/nano11020307.
Keller, C., Desrues, A., Karuppiah, S., Martin, E., Alper, J. P., Boismain, F., Villevieille, C., Herlin-Boime, N., Haon, C., & Chenevier, P. (2021). Effect of Size and Shape on Electrochemical Performance of Nano-Silicon-Based Lithium Battery. Nanomaterials (Basel, Switzerland), 11(2), . https://doi.org/10.3390/nano11020307
Keller, Caroline, et al. "Effect of Size and Shape on Electrochemical Performance of Nano-Silicon-Based Lithium Battery." Nanomaterials (Basel, Switzerland) vol. 11,2 (2021). doi: https://doi.org/10.3390/nano11020307
Keller C, Desrues A, Karuppiah S, Martin E, Alper JP, Boismain F, Villevieille C, Herlin-Boime N, Haon C, Chenevier P. Effect of Size and Shape on Electrochemical Performance of Nano-Silicon-Based Lithium Battery. Nanomaterials (Basel). 2021 Jan 25;11(2). doi: 10.3390/nano11020307. PMID: 33504062; PMCID: PMC7912472.
Copy Download .nbib Format: NLM
Nurse-like cells promote CLL survival through LFA-3/CD2 interactions.

Oncotarget

Boissard F, Tosolini M, Ligat L, Quillet-Mary A, Lopez F, Fournié JJ, Ysebaert L, Poupot M.
PMID: 28881725
Oncotarget. 2016 Nov 26;8(32):52225-52236. doi: 10.18632/oncotarget.13660. eCollection 2017 Aug 08.

In the tumoral micro-environment (TME) of chronic lymphocytic leukemia (CLL), nurse-like cells (NLC) are tumor-associated macrophages which play a critical role in the survival and chemoresistance of tumoral cells. This pro-survival activity is known to involve soluble factors, but...

Cite
Boissard F, Tosolini M, Ligat L, et al. Nurse-like cells promote CLL survival through LFA-3/CD2 interactions. Oncotarget. 2016;8(32):52225-52236doi: 10.18632/oncotarget.13660.
Boissard, F., Tosolini, M., Ligat, L., Quillet-Mary, A., Lopez, F., Fournié, J. J., Ysebaert, L., & Poupot, M. (2017). Nurse-like cells promote CLL survival through LFA-3/CD2 interactions. Oncotarget, 8(32), 52225-52236. https://doi.org/10.18632/oncotarget.13660
Boissard, Frédéric, et al. "Nurse-like cells promote CLL survival through LFA-3/CD2 interactions." Oncotarget vol. 8,32 (2017): 52225-52236. doi: https://doi.org/10.18632/oncotarget.13660
Boissard F, Tosolini M, Ligat L, Quillet-Mary A, Lopez F, Fournié JJ, Ysebaert L, Poupot M. Nurse-like cells promote CLL survival through LFA-3/CD2 interactions. Oncotarget. 2016 Nov 26;8(32):52225-52236. doi: 10.18632/oncotarget.13660. eCollection 2017 Aug 08. PMID: 28881725; PMCID: PMC5581024.
Copy Download .nbib Format: NLM
Detoxification of ochratoxin A, a food contaminant: Prevention of growth of Aspergillus ochraceus and its production of ochratoxin A.

Mycotoxin research

Deberghes P, Betbeder AM, Boisard F, Blanc R, Delaby JF, Krivobok S, Steiman R, Seigle-Murandi F, Creppy E.
PMID: 23606034
Mycotoxin Res. 1995 Mar;11(1):37-47. doi: 10.1007/BF03192060.

The toxicity of ochratoxin A (OTA), a mycotoxin produced by fungi ofAspergillus orPenicillium genera is now well documented. Its nephrotoxicity, immunosuppression, teratogenicity, and carcinogenicity have been widely studied. Physical and biochemical methods have been studied to prevent these toxinogenicAspergillus...

Cite
Deberghes P, Betbeder AM, Boisard F, et al. Detoxification of ochratoxin A, a food contaminant: Prevention of growth of Aspergillus ochraceus and its production of ochratoxin A. Mycotoxin Res. 1995;11(1):37-47doi: 10.1007/BF03192060.
Deberghes, P., Betbeder, A. M., Boisard, F., Blanc, R., Delaby, J. F., Krivobok, S., Steiman, R., Seigle-Murandi, F., & Creppy, E. (1995). Detoxification of ochratoxin A, a food contaminant: Prevention of growth of Aspergillus ochraceus and its production of ochratoxin A. Mycotoxin research, 11(1), 37-47. https://doi.org/10.1007/BF03192060
Deberghes, P, et al. "Detoxification of ochratoxin A, a food contaminant: Prevention of growth of Aspergillus ochraceus and its production of ochratoxin A." Mycotoxin research vol. 11,1 (1995): 37-47. doi: https://doi.org/10.1007/BF03192060
Deberghes P, Betbeder AM, Boisard F, Blanc R, Delaby JF, Krivobok S, Steiman R, Seigle-Murandi F, Creppy E. Detoxification of ochratoxin A, a food contaminant: Prevention of growth of Aspergillus ochraceus and its production of ochratoxin A. Mycotoxin Res. 1995 Mar;11(1):37-47. doi: 10.1007/BF03192060. PMID: 23606034.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries